Caraluzzi's Markets food recall: Caraluzzi's Italian Style Seafood Burgers
Key facts
- Agency
- U.S. Food and Drug Administration (FDA)
- Program
- Food
- Classification
- Class I
- Status
- Terminated
- Event ID
- 96670
- Recall initiated
- Apr 2, 2025
- Classified by FDA
- Apr 30, 2025
- Posted in Enforcement Report
- May 7, 2025
- Terminated
- Aug 5, 2025
- Recalling firm
- Caraluzzi's Markets
- Firm location
- BETHEL, CT, United States
- Initiated by
- Voluntary: Firm initiated
- Firm notified customers by
- Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
- Products in this event
- 1
What to do
Compare the product name, size, UPC, lot codes and dates below with the product you have. If it matches, do not eat it. Follow the firm's instructions to return it or throw it away.
Reason for recall
Product contains undeclared egg.
What the classification means
- Class I: FDA's most serious category: there is a reasonable probability that using or being exposed to the product will cause serious health problems or death.
About this recall
The firm started this recall on Apr 2, 2025. FDA classified it 28 days later, on Apr 30, 2025. Distribution reported by FDA: CT
Recalled products (1)
F-0747-2025 Class I Terminated
Caraluzzi's Italian Style Seafood Burgers, 8oz; INGREDIENTS: Cod, Salmon, Shrimp, Scallops, Onions, Olive Oil, White Wine, Parsley, Sodium Caseinate (A Milk Derivative), Spices, Garlic, Salt, Paprika, Enzyme.; CONTAINS: Crustacean Shellfish, Fish, Milk; Distributed by Caraluzzi's Markets, Bethel, CT 06801; UPC: 0 95864 80008 8
Codes / lots: Expiration: 1/16/2026
Quantity: 79 units
Source and freshness
- Source
- U.S. Food and Drug Administration (FDA) Enforcement Report, via the openFDA food enforcement dataset
- Official notice
- FDA Enforcement Report, event 96670
- Raw record
- openFDA API (JSON)
- Dataset last updated by FDA
- Nov 3, 2026
- Imported by RecallRadar
- Nov 4, 2026
Enforcement Report entries describe recalls FDA has classified. They are not always the same as a company press release. If something here differs from FDA's record, FDA's record is correct — please tell us.